DNA Topoisomerase II as the Cellular Target of a Novel Antitumor Agent ICRF-193, a Bisdioxopiperazine Derivative, inXenopusEgg Extract

By Sato M.   Ishida R.   Ohsumi K.   Narita T.   Andoh T.  

Biochemical and Biophysical Research Communications, Vol. 235, Iss. 3, 1997-06 ,pp. : 571-575

Elsevier

Access to resources Recommend Favorite

Cellular distribution of mammalian DNA topoisomerase II is determined by its catalytically dispensable C-terminal domain

By Adachi Noritaka   Miyaike Mitsuko   Kato Satoshi   Kanamaru Ryunosuke   Koyama Hideki   Kikuchi Akihiko  

Nucleic Acids Research, Vol. 25, Iss. 15, 1997-01 ,pp. : 3135-3142

Oxford University Press

Access to resources Recommend Favorite

Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani : a key molecular target in antileishmanial therapy

By Ghosh M.   Bandopadhyay S.   Das A.   Dasgupta A.   Sharma S.   Sengupta T.   Majumder H.K.  

Nucleic Acids Research, Vol. 29, Iss. 9, 2001-05 ,pp. : 1844-1851

Oxford University Press

Access to resources Recommend Favorite

Inhibition of the Topoisomerase II-DNA Cleavable Complex by the ortho -Quinone Derivative of the Antitumor Drug Etoposide (VP-16)

By Gantchev T.G.   Hunting D.J.  

Biochemical and Biophysical Research Communications, Vol. 237, Iss. 1, 1997-08 ,pp. : 24-27

Elsevier

Access to resources Recommend Favorite

Cloning, functional analysis and post‐transcriptional regulation of a type II DNA topoisomerase from Leishmania infantum . A new potential target for anti‐parasite drugs

By Hanke Tobias   Ramiro María J.   Trigueros Sonia  

Nucleic Acids Research, Vol. 31, Iss. 16, 2003-08 ,pp. : 4917-4928

Oxford University Press

Access to resources Recommend Favorite